Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.

par Fearon, D T
Publié 1991

Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

par Fearon, D T, Austen, K F
Publié 1977

Properdin: initiation of alternative complement pathway.

par Fearon, D T, Austen, K F
Publié 1975

Experiences of breast cancer in Arab countries. A thematic synthesis

par Fearon, D., Hughes, S., Brearley, S. G.
Publié dans Qual Life Res (2019)

Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

par Weis, J J, Tedder, T F, Fearon, D T
Publié 1984

Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis.

par Lee, J, Hakim, R M, Fearon, D T
Publié 1984

Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.

par Czop, J K, Fearon, D T, Austen, K F
Publié 1978

Genetic regulation of a structural polymorphism of human C3b receptor.

par Wong, W W, Wilson, J G, Fearon, D T
Publié 1983

Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.

par Daha, M R, Fearon, D T, Austen, K F
Publié 1976

Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes.

par Carter, R H, Park, D J, Rhee, S G, Fearon, D T
Publié 1991

Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.

par Ahearn, J M, Hayward, S D, Hickey, J C, Fearon, D T
Publié 1988

Control of the amplification convertase of complement by the plasma protein beta1H.

par Weiler, J M, Daha, M R, Austen, K F, Fearon, D T
Publié 1976

Lateral distribution and diffusion of the C3b receptor of complement, HLA antigens, and lipid probes in peripheral blood leukocytes.

par Petty, H R, Smith, L M, Fearon, D T, McConnell, H M
Publié 1980

Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in...

par Kazatchkine, M D, Fearon, D T, Appay, M D, Mandet, C, Bariety, J
Publié 1982

Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b.

par Wong, W W, Klickstein, L B, Smith, J A, Weis, J H, Fearon, D T
Publié 1985

Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

par Wilson, J G, Jack, R M, Wong, W W, Schur, P H, Fearon, D T
Publié 1985

CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation.

par Crooks, M E, Littman, D R, Carter, R H, Fearon, D T, Weiss, A, Stein, P H
Publié 1995

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

par Fingeroth, J D, Weis, J J, Tedder, T F, Strominger, J L, Biro, P A, Fearon, D T
Publié 1984

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

par Connell, C. M., Raby, S., Beh, I., Flint, T. R., Williams, E. H., Fearon, D. T., Jodrell, D. I., Janowitz, T.
Publié dans Ann Oncol (2017)

A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.

par Dal Porto, J, Johansen, T E, Catipović, B, Parfiit, D J, Tuveson, D, Gether, U, Kozlowski, S, Fearon, D T, Schneck, J P
Publié 1993